User Experience of a Telemedicine Platform for the Follow-up of Post Intensive Care Syndrome (PICS)
Launched by PARC TAULI RESEARCH AND INNOVATION INSTITUTE FOUNDATION · May 27, 2024
Trial Information
Current as of February 18, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (≥18 years)
- • Admitted to a medical/surgical ICU
- • For respiratory failure, cardiogenic shock, or septic shock
- • With an expected ICU stay of ≥48 hours
- • Catalan and/or Spanish speakers
- • Who are able to give informed consent by themselves
- Exclusion Criteria:
- • History of intellectual disability or other neurodevelopmental disorders, such as autism spectrum disorder
- • History of neurological disorders, dementia or other neurodegenerative diseases, such as epilepsy, Alzheimer's disease, Parkinson's disease or multiple sclerosis
- • History of brain damage, such as traumatic brain injury or stroke
- • History of severe psychiatric illness, such as psychotic, bipolar, depressive, obsessive-compulsive, post-traumatic or personality disorder
- • Suspected or confirmed substance use disorder
- • Suspected or confirmed communicable disease in an isolated patient
- • Uncorrected hearing or visual impairment
- • Enrolled in another trial that does not allow co-enrollment
About Parc Tauli Research And Innovation Institute Foundation
The Parc Taulí Research and Innovation Institute Foundation is a leading clinical trial sponsor dedicated to advancing medical research and innovation in healthcare. Located in Sabadell, Spain, the foundation is affiliated with the Parc Taulí University Hospital, which provides a robust clinical environment for conducting high-quality research. The foundation focuses on multidisciplinary collaboration, fostering partnerships with academic institutions, industry stakeholders, and healthcare professionals to translate scientific discoveries into practical applications. With a commitment to ethical standards and patient-centered approaches, the foundation aims to improve health outcomes through cutting-edge clinical trials and innovative solutions in medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0